Paper Details

  1. Home
  2. Paper Details

Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.

Author: ClarkL G O, ClarkO A C, SasseA D, SasseE C, UlloaL

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Malignant melanoma is a very aggressive skin cancer that is becoming more common. Surgery is the main treatment for early stages, but most cases that spread are incurable because melanoma doesn't respond well to most systemic treatments. While promising new treatments are being studied, they often have severe side effects and are expensive. Combining chemotherapy and immunotherapy has shown some improvement, but it's unclear if this is better than chemotherapy alone.
Paper Details　
Original Abstract of the Article :
Malignant melanoma, one of the most aggressive of all skin cancers, is increasing in incidence throughout the world. Surgery remains the cornerstone of curative treatment in earlier stages. Metastatic disease is incurable in most affected people, because melanoma does not respond to most systemic tr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD005413.pub2

データ提供：米国国立医学図書館（NLM）

Chemoimmunotherapy: A New Frontier for Metastatic Malignant Melanoma

Malignant melanoma, a highly aggressive form of skin cancer, poses a significant challenge to healthcare providers. This research focuses on exploring the potential benefits of chemoimmunotherapy, a combination of chemotherapy and immunotherapy, for treating metastatic malignant melanoma. The authors examine the available evidence to determine whether chemoimmunotherapy offers a significant advantage over chemotherapy alone.

A Shifting Sandscape: Fighting Metastatic Melanoma

While surgery remains the cornerstone of treatment for early-stage melanoma, metastatic melanoma is often incurable. Chemoimmunotherapy has emerged as a potential alternative, but its efficacy compared to chemotherapy alone remains unclear. This review aims to shed light on this crucial question, providing valuable insights for clinicians and researchers.

Hope on the Horizon: New Treatments for Melanoma

The study highlights the need for further investigation into the role of chemoimmunotherapy in treating metastatic melanoma. While promising results have been reported, more evidence is needed to confirm its efficacy and safety compared to conventional chemotherapy. This research underscores the importance of continuous innovation and research in the fight against melanoma.

Dr. Camel's Conclusion

This review delves into the potential benefits of chemoimmunotherapy for metastatic melanoma. While promising results have been reported, further research is needed to confirm its efficacy and safety compared to conventional chemotherapy. This study highlights the ongoing search for effective treatments for this aggressive form of cancer.

Date :
  1. Date Completed 2007-05-08
  2. Date Revised 2020-12-26
Further Info :

Pubmed ID

17253556

DOI: Digital Object Identifier

10.1002/14651858.CD005413.pub2

Related Literature

Article Analysis
・Effective treatment of melanoma
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.